Overview

Different Premedication in Children

Status:
Recruiting

Trial end date:
2022-09-01

Target enrollment:
0

Participant gender:
All

Summary

The investigators studied the effects of intranasal dexmedetomidine compared with oral midazolam with different doses for premedication in children. One hundred and twenty children aged between 2 and 12 years were randomly allocated to one of four groups:2.5µg/kg intranasal dexmedetomidine group ; 0.5mg/kg oral midazolam group;0.05 mg/kg intravenous injection midazolam group; no premedication group. Sedation levels 10, 20, and 30min after premedication were evaluated using a 5-point sedation scale. A 4-point emotional state score was used to evaluate participators when they were separated from their parents and their response to intravenous cannulation or facemask application. Agitation scores (Pediatric Anesthe-sia Emergence Delirium [PAED] scale) and POV were assessed in the postanesthetic care unit (PACU).Times to endotracheal tube or laryngeal mask airway removal, discharge from the PACU and patients' satisfaction degree were also assessed.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Eye & ENT Hospital of Fudan University

Treatments:

Dexmedetomidine
Midazolam

Criteria

Inclusion Criteria:

-

Exclusion Criteria:

- a recent history of upper respiratory tract infection, a known allergy to
dexmedetomidine or midazolam, inability to understand the consent process or parental
refusal.